Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Interim Management Statement

14 May 2010 08:51

RNS Number : 9274L
Computacenter PLC
14 May 2010
Ā 



Interim Management Statement

Ā 

14th May 2010

Ā 

Computacenter plc, the independent IT services provider, is today holding its Annual General Meeting and publishes its Interim Management Statement based on unaudited financial information, for the period from 1 January 2010 to date.

Ā 

Financial Performance

Ā 

Group revenue, for the first quarter, increased by 7% to £634.4m on an as reported basis, which includes the effects of disposals, acquisitions and small currency movements. Excluding these effects, Group revenue for the first quarter increased by 8% to £616.0m and has seen similar growth rates in Q2 to date. Our Services revenue grew by 2% in Q1, and we have seen a small increase in this growth in Q2 to date. Group product revenue grew by 9% in Q1, including disposals, acquisitions and currency movements and by 12% excluding these effects and the growth has been maintained in Q2.

Ā 

We have managed to achieve these growth rates with further reductions compared to Q1 2009, albeit small, to our cost base from last year's cost reduction program without exceptional costs.Ā 

Ā 

In the UK, we have seen a strong rebound in product sales, with growth of 20% excluding the disposal of CCD. This growth was flattered by one large project, which is not ongoing. However, excluding this project, the underlying growth rate was still greater than 10%, which has been maintained in Q2. UK services grew by 3% in Q1 and has increased further in Q2, due to new business gains.

Ā 

As previously reported, we had a slow start to the year in Germany, but there was a material pick up in March. In the first quarter as a whole, product revenues grew 12% but only 1% if the acquisition of becom is excluded. Services declined by 3%, which was not materially affected by the acquisition. The improved trading in March has continued into Q2.

Ā 

In France, the first quarter services revenue increased by 13% and product revenue by 7%. However, gross margins are lower than in Q1 2009, which was an artificially high position. Q2 to date has seen a similar trading performance to Q1.Ā 

Ā 

Financial Position

Ā 

Despite the growth in our product business, our balance sheet continues to strengthen. At the end of Q1, net cash, excluding Customer Specific Financing (CSF), was approximately £89m (£86m at the end of Q4 2009). Net Funds including CSF was £53.3m (£37.3m at the end of Q4 2009). This position is still benefitting from an extended credit scheme with one of our major vendors, to the extent of approximately £30 million. There is no material change in this position since the end of Q1, despite the cash cost of paying the additional interim dividend totalling £11.8 million on 1 April 2010.

Ā 

Outlook

Ā 

After a challenging 2009 for our product business, we saw a strong rebound in Q1 2010, particularly in the UK. Whilst it is not certain that these growth rates can be maintained throughout the year, the signs are encouraging. Our services business has seen slower growth than we have become used to, but we are expecting this to improve as the year progresses. After a slow start to the year, our German business is showing some improvement. Trading this year to date across the Group has increased our confidence of another year of progress for Computacenter, in line with management expectations.Ā 

Ā 

Our next scheduled trading update will be the pre-close briefing prior to our Interim Results, which is scheduled for 13th July 2010.

Ā 

Enquiries

Ā 

Computacenter plc

Ā 

Mike Norris, Chief Executive 01707 631601

Ā 

Tony Conophy, Finance Director 01707 631515

Ā 

Tessa Freeman, PR Manager 01707 631514

Ā 

Tulchan Communications 020 7353 4200

Ā 

Andrew Grant

Ā 

Stephen Malthouse

Ā 

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
IMSUSSBRRSAVARR
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.